Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ: IOVA )

6.400 -0.770 (-10.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,544,477
Open 7.000
Bid (Size) 6.390 (8)
Ask (Size) 6.450 (4)
Prev. Close 7.170
Today's Range 6.240 - 7.025
52wk Range 6.240 - 18.33
Shares Outstanding 304,780,790
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Iovance Biotherapeutics Shares Are Falling Today: What's Going On?
Shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) are trading lower Friday. The company announced the inducement stock option grants under Nasdaq Listing Rule 5635(c)(4). 
Via Benzinga
3 Mid-Cap Stocks That Could Take Off in 2025
Via The Motley Fool

Performance

YTD
-17.84%
-17.84%
1 Month
-18.26%
-18.26%
3 Month
-34.49%
-34.49%
6 Month
-26.27%
-26.27%
1 Year
-23.54%
-23.54%

More News

Read More
Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Prediction: This Stock Will Beat the Market in 2025
Via The Motley Fool
Peering Into Iovance Biotherapeutics's Recent Short Interest
Via Benzinga
Is Iovance Biotherapeutics Stock a Millionaire Maker?
Via The Motley Fool
If I Could Only Buy 3 Stocks in the Last Month of 2024, I'd Pick These
Via The Motley Fool
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
Via The Motley Fool
3 Monster Stocks to Hold for the Next 10 Years
Via The Motley Fool
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
Via Benzinga
Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back
Via The Motley Fool
2 Innovative Stocks That Could Deliver Outsize Returns
Via The Motley Fool
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
Via The Motley Fool
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
A Peek at Iovance Biotherapeutics's Future Earnings
Via Benzinga
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Is Iovance Biotherapeutics Stock a Buy?
Via The Motley Fool
Why Iovance Biotherapeutics Stock Triumphed on Thursday
Via The Motley Fool
3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow
Via The Motley Fool
3 Things You Need to Know if You Buy Iovance Biotherapeutics Today
Via The Motley Fool
AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
This Is the Biggest Risk With Iovance Biotherapeutics Stock
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.